Conditions: Allergic Asthma
Keywords: AQUA anti-CD11 CD11a Asthma Allergy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 61
Healthy volunteers: no

Brief summary:
This was a multicenter, randomized, double-blind, parallel-group, three-arm, placebo-controlled study designed to demonstrate the efficacy of two different formulations of omalizumab compared with placebo in reducing the airway reaction to an inhaled aeroallergen solution in adult subjects with mild allergic asthma.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: omalizumab intervention 2: omalizumab intervention 3: placebo
Intervention descriptions: intervention 1: Aged Liquid; subcutaneous repeating dose intervention 2: Lyophilized; subcutaneous repeating dose intervention 3: Subcutaneous repeating dose

Protocol document: